Sources Say Teva Willing To Pay $6 Billion In Third Try To Acquire Cipla
This article was originally published in PharmAsia News
Executive Summary
Teva Pharmaceutical Industries refuses to take Cipla's nahi (no) for an answer and now is willing to pay up to $6 billion for the India drug maker, according to sources.